Clinical Trial

The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is a multicenter randomized controlled trial designed to investigate the effects of Clostridium butyricum on adverse events during adjuvant treatment for colorectal cancer.
Trial Details
NCT Number NCT07152886
Lead Sponsor The Affiliated Hospital of Qingdao University
Collaborators: Shandong Provincial Hospital, Linyi People's Hospital, Shandong Cancer Hospital and Institute, Yantai Yuhuangding Hospital, Jining First People's Hospital, Rizhao People's Hospital, Qianfoshan Hospital, Weifang People's Hospital, Qilu Hospital of Shandong University, Taian City Central Hospital, The Affiliated Hospital of Shandong Second Medical University, Dongying People's Hospital
Conditions Colorectal Cancer, Chemotherapeutic Toxicity
Enrollment 238 participants
Start Date 2025-10-31
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-03